169 related articles for article (PubMed ID: 31015643)
1. Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities.
Martínez-Bosch N; Rodriguez-Vida A; Juanpere N; Lloreta J; Rovira A; Albanell J; Bellmunt J; Navarro P
Nat Rev Urol; 2019 Jul; 16(7):433-445. PubMed ID: 31015643
[TBL] [Abstract][Full Text] [Related]
2. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies.
Kapetanakis NI; Busson P
Front Immunol; 2023; 14():1145268. PubMed ID: 36817445
[TBL] [Abstract][Full Text] [Related]
3. Galectins and urological cancer.
Oka N; Takenaka Y; Raz A
J Cell Biochem; 2004 Jan; 91(1):118-24. PubMed ID: 14689585
[TBL] [Abstract][Full Text] [Related]
4. Galectins as modulators of tumour progression.
Liu FT; Rabinovich GA
Nat Rev Cancer; 2005 Jan; 5(1):29-41. PubMed ID: 15630413
[TBL] [Abstract][Full Text] [Related]
5. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
6. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
[TBL] [Abstract][Full Text] [Related]
7. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
8. Roles of Galectin-7 in Cancer.
Kaur M; Kaur T; Kamboj SS; Singh J
Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
[TBL] [Abstract][Full Text] [Related]
9. Galectins in the Tumor Microenvironment: Focus on Galectin-1.
Martínez-Bosch N; Navarro P
Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.
Ahmed H; Banerjee PP; Vasta GR
Biochem Biophys Res Commun; 2007 Jun; 358(1):241-6. PubMed ID: 17481580
[TBL] [Abstract][Full Text] [Related]
12. Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.
Gentilini LD; Jaworski FM; Tiraboschi C; Pérez IG; Kotler ML; Chauchereau A; Laderach DJ; Compagno D
Oncotarget; 2017 Jul; 8(27):44654-44668. PubMed ID: 28591719
[TBL] [Abstract][Full Text] [Related]
13. Examining the co-occurrence of bladder and prostate cancer: a worthwhile investigation?
Kellen E; Zeegers MP; Joniau S; Buntinx F
Future Oncol; 2007 Oct; 3(5):515-9. PubMed ID: 17927517
[TBL] [Abstract][Full Text] [Related]
14. The role of galectins in colorectal cancer progression.
Barrow H; Rhodes JM; Yu LG
Int J Cancer; 2011 Jul; 129(1):1-8. PubMed ID: 21520033
[TBL] [Abstract][Full Text] [Related]
15. The expression and function of galectins in skin physiology and pathology.
Wu NL; Liu FT
Exp Dermatol; 2018 Mar; 27(3):217-226. PubMed ID: 29427464
[TBL] [Abstract][Full Text] [Related]
16. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
17. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
18. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer.
Rabinovich GA; Liu FT; Hirashima M; Anderson A
Scand J Immunol; 2007; 66(2-3):143-58. PubMed ID: 17635792
[TBL] [Abstract][Full Text] [Related]
19. Targeting death receptors in bladder, prostate and renal cancer.
O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
[TBL] [Abstract][Full Text] [Related]
20. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
Rabinovich GA; Conejo-García JR
J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
